ArticleJNCI cancer spectrum2019

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer.

Steven A Buechler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.